Insider · CIK 0001319446

Borisy Alexis

Reports to the SEC for 11 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001319446

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,127 sh	—	—	3,127
2026-06-18	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+1,191 sh	—	—	2,340,075
2026-06-11	PBLSParabilis Medicines, Inc.C Conversion	Director	CConversion	+105K sh	—	—	105,414
2026-06-11	PBLSParabilis Medicines, Inc. · Series F Preferred StockC Conversion	Director	CConversion	+162K sh	—	—	0
2026-06-09	PBLSParabilis Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,215
2026-06-09	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.9K sh	—	—	32,947
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,570 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,500 sh	—	—	0
2025-07-17	Blueprint Medicines CorpU Disposition from Tender	Director	UDisposition from Tender	−74.2K sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,875 sh	—	—	0
2025-07-17	Blueprint Medicines CorpD Disposition to Issuer	Director	DDisposition to Issuer	−3,902 sh	—	—	74,160
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,500 sh	—	—	0
2025-07-17	Blueprint Medicines CorpStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,300 sh	—	—	0
2025-06-26	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.6K sh	—	—	11,574
2025-06-26	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+3,142 sh	—	—	2,338,884
2025-06-18	Blueprint Medicines CorpA Award	Director	AAward	+3,902 sh	$128.12	+$500K	78,062
2025-06-06	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+137K sh	—	—	136,681
2025-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2025-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+6,250 sh	—	—	17,500
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,700
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,800 sh	—	—	2,336,294
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,955
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,248 sh	—	—	2,335,742
2024-06-12	Blueprint Medicines CorpA Award	Director	AAward	+2,242 sh	—	—	74,160
2024-06-12	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+4,570 sh	—	—	4,570
2024-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2024-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+6,250 sh	—	—	11,250
2024-06-03	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+102K sh	—	—	102,225
2023-11-09	EQRx, Inc.Earn-out SharesD Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−2.89M sh	—	—	0
2023-11-09	EQRx, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−2.19M sh	—	—	0
2023-11-09	RVMDRevolution Medicines, Inc. · Earn-out SharesA Award	Director	AAward	+296K sh	—	—	296,039
2023-11-09	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+2.09M sh	—	—	2,331,494
2023-11-09	EQRx, Inc.D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−18.8M sh	—	—	0
2023-06-22	OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	71,918
2023-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-06-08	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	239,822
2023-06-08	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2023-06-06	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-06-06	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-05-31	RLAYRelay Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+66.1K sh	—	—	66,055
2023-01-01	EQRx, Inc.Earn-out SharesA Award	Director, Executive Chairman	AAward	+15.1K sh	—	—	2,892,491
2022-07-14	OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award	Director	AAward	−30K sh	—	—	30,000
2022-06-21	Blueprint Medicines CorpA Award	Director	AAward	+2,600 sh	—	—	69,318
2022-06-21	Blueprint Medicines CorpStock Option (Right to Buy)A Award	Director	AAward	—	—	—	5,300
2022-06-16	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2022-06-16	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	54,918
2022-06-08	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Jun 234
Borisy Alexis0001610717-26-000289
SEC(opens sec.gov)
Jun 154
Borisy Alexis0001193125-26-271300
SEC(opens sec.gov)
Jun 114
Borisy Alexis0001193125-26-267806
SEC(opens sec.gov)
Jun 104
Borisy Alexis0001193125-26-265906
SEC(opens sec.gov)
Jul 214
Borisy Alexis0001104659-25-069385
SEC(opens sec.gov)
Jun 304
Borisy Alexis0001610717-25-000270
SEC(opens sec.gov)
Jun 244
Borisy Alexis0001415889-25-018075
SEC(opens sec.gov)
Jun 94
Borisy Alexis0000950170-25-083903
SEC(opens sec.gov)

Companies

Address

C/O REVOLUTION MEDICINES, INC. 700 SAGINAW DR

REDWOOD CITY, CA, 94063